Skip to main content
. 2020 Feb 5;10:29. doi: 10.3389/fonc.2020.00029

Figure 9.

Figure 9

Comparison on adverse event rate between thermal intravesical chemotherapy and normal temperature intravesical chemotherapy after subgroup analysis stratified by chemotherapeutic agent used in thermal intravesical chemotherapy.